FDA Publishes Final Guidance: Quality System Approach to Pharmaceutical cGMP Regulations

GMP News No. 808

GMP News
5 October 2006
 

FDA Publishes Final Guidance:
Quality System Approach to Pharmaceutical cGMP Regulations

 
On 29 September, the FDA issued the final Guidance on Quality Systems to facilitate the modernisation of drug manufacturing. It is somehow surprising how quickly this guidance was finalised. And it underlines how important this topic is to the FDA. Harmonisation efforts with ICH Q10 cannot be seen in this document.

When comparing the final guidance with the draft document, one can see that mostly changes in the wording have been made. Nevertheless, in some cases the different wording results in a different meaning. For example, the draft document "is not intended to create new expectations ..." whereas the final guidance "is not intended to create new requirements ...". So the FDA does give a clear statement on what their expectations are regarding the Quality System. In the case of validation, the FDA mentions the ASQ document (The ASQ Auditing Handbook, 3rd edition, ASQ Quality Audit Division, J.P. Russel, Editor) and not the "old" FDA Process Validation Guide.

On the whole, there are no big changes compared to the draft. But now, the FDA has issued a guidance which implements ISO 9001 elements, Quality Risk Management and a CAPA system in their expectations. "This guidance incorporates modern quality principles into FDA's approach to manufacturing, encouraging industry adoption of new technological advances and integrated quality systems." said Dr Janet Woodcock, FDA Deputy Commissioner for Operations.

This document contributes to the goals of the Agency's "cGMPs for the 21st Century" and "Critical Path Initiative" (www.fda.gov/oc/initiatives/criticalpath/) which seek to modernise the development of new drugs.

The full text of the guidance can be found at:
http://www.fda.gov/cber/gdlns/qualsystem.pdf
  

The following GMP Education Course explains the content of the Final Guidance on Quality Systems:

If you are interested in modern elements of a Quality System (like CAPA, Product Quality Review, FMEA) we recommend:

Comparison between draft and final version:
Participants in the above events receive on demand a comparison of the final version with the draft where the deleted and inserted passages are marked. When you register for one of these events, simply indicate your e-mail address and the wish to receive a copy of the comparison. Click here to view an excerpt.

 
Author:
Wolfgang Schmitt
On behalf of ECA
 

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK